Protagonist Therapeutics Inc (PTGX)
30.41
-0.13
(-0.43%)
USD |
NASDAQ |
May 24, 16:00
30.44
+0.03
(+0.10%)
After-Hours: 20:00
Protagonist Therapeutics 1 Year Total Returns (Daily): 21.06% for May 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 24, 2024 | 21.06% |
| May 23, 2024 | 21.19% |
| May 22, 2024 | 23.87% |
| May 21, 2024 | 21.73% |
| May 20, 2024 | 20.00% |
| May 17, 2024 | 16.75% |
| May 16, 2024 | 25.75% |
| May 15, 2024 | 21.18% |
| May 14, 2024 | 16.71% |
| May 13, 2024 | 15.57% |
| May 10, 2024 | 12.83% |
| May 09, 2024 | 11.96% |
| May 08, 2024 | 8.74% |
| May 07, 2024 | 3.95% |
| May 06, 2024 | 5.04% |
| May 03, 2024 | 6.71% |
| May 02, 2024 | 7.63% |
| May 01, 2024 | 8.54% |
| April 30, 2024 | 11.11% |
| April 29, 2024 | 13.10% |
| April 26, 2024 | 8.13% |
| April 25, 2024 | 6.06% |
| April 24, 2024 | 8.21% |
| April 23, 2024 | 11.78% |
| April 22, 2024 | 10.78% |
| Date | Value |
|---|---|
| April 19, 2024 | 9.16% |
| April 18, 2024 | 8.66% |
| April 17, 2024 | 24.01% |
| April 16, 2024 | 39.33% |
| April 15, 2024 | 41.84% |
| April 12, 2024 | 44.99% |
| April 11, 2024 | 50.82% |
| April 10, 2024 | 51.11% |
| April 09, 2024 | 57.72% |
| April 08, 2024 | 52.08% |
| April 05, 2024 | 55.38% |
| April 04, 2024 | 28.31% |
| April 03, 2024 | 23.01% |
| April 02, 2024 | 21.70% |
| April 01, 2024 | 22.96% |
| March 28, 2024 | 37.63% |
| March 27, 2024 | 30.88% |
| March 26, 2024 | 35.07% |
| March 25, 2024 | 34.54% |
| March 22, 2024 | 33.22% |
| March 21, 2024 | 24.67% |
| March 20, 2024 | 26.78% |
| March 19, 2024 | 28.55% |
| March 18, 2024 | 26.94% |
| March 15, 2024 | 20.50% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.21%
Minimum
Jul 01 2022
450.3%
Maximum
Mar 22 2021
56.47%
Average
47.55%
Median
Dec 28 2021
1 Year Total Returns (Daily) Benchmarks
| Lifecore Biomedical Inc | -32.78% |
| SELLAS Life Sciences Group Inc | -10.26% |
| Akebia Therapeutics Inc | -23.08% |
| Immuneering Corp | -78.62% |
| Moderna Inc | 26.61% |